Medical Journals

The Cannabinoid Cb1 Receptor Antagonist Am251 Does Not Modify Methamphetamine Reinstatement of Responding.

Authors:
  • Boctor Sherin Y
  • Martinez Joe L
  • Koek Wouter
  • France Charles P

From: Cajal Neuroscience Institute, Department of Biology, University of Texas at San Antonio, San Antonio, Texas 78249, USA.

European journal of pharmacology

  • Publish Date: Sep 2007
  • ISSN: 0014-2999
  • Volume: 571
  • Issue: 1
  • Pages: 39-43
  • Medium: Print
  • Language: English
  • Citation (JAMA): Boctor Sherin Y, Martinez Joe L, Koek Wouter, et al. The Cannabinoid Cb1 Receptor Antagonist Am251 Does Not Modify Methamphetamine Reinstatement of Responding.. Eur. J. Pharmacol. Sep 2007;571:39-43

Abstract

Cannabinoid CB(1) receptor antagonists can decrease methamphetamine self-administration. This study examined whether the CB(1) receptor antagonist AM251 [N-(piperidin-1-yl)-5-(4-indophonyl)-1-(2,4-dichlorophenyl)-4-methyl-1H-pyrazole-3-carboxamide] modifies reinstatement in rats that previously self-administered methamphetamine. Rats (n=10) self-administered methamphetamine (0.1 mg/kg/infusion) under a fixed ratio 2 schedule. Non-contingent methamphetamine (0.01-1.78 mg/kg, i.v.) yielded responding for saline (reinstatement) that was similar to responding for self-administered methamphetamine. AM251 (0.032-0.32, i.v.) did not affect methamphetamine-induced reinstatement but significantly attenuated Delta(9)-tetrahydrocannabinol (2.0 mg/kg, i.p.)-induced hypothermia. These data fail to support a role for endogenous cannabinoids or cannabinoid CB(1) receptors in reinstatement and, therefore, relapse to stimulant abuse.

Mesh Headings (Keywords): Animals, Body Temperature, Central Nervous System Stimulants, Dose-Response Relationship, Drug, Infusions, Intravenous, Injections, Intraperitoneal, Male, Methamphetamine, Piperidines, Pyrazoles, Rats, Rats, Wistar, Receptor, Cannabinoid, CB1, Reinforcement Schedule, Self Administration, Tetrahydrocannabinol, Time Factors


Check for Full Text / PubMed Unique Identifier (PMID): 17628534


This abstract is part of PubMed, a service of the U.S. National Library of Medicine. PubMed includes more than 17 million citations from MEDLINE and other life science journals for biomedical articles. See Copyright and Disclaimers.

Linked medical terms appearing on this page are added by Healia to help readers find more information and are not part of the original PubMed document.

The data herein was last updated on July 8th, 2008 and may not reflect the most current and accurate data available from NLM.


Advertisements

About | Privacy Policy | Business Solutions | Advertise | Contact | Add Healia to your site

©2012. Healia / Meredith Corporation  

Use of this site constitutes acceptance of our Terms of Service and Privacy Policy. All content on this Web site, including medical opinion and any other health-related information, is for informational purposes only and should not be used for a specific diagnosis or individual treatment plan for any situation. Use of this site and the information contained herein does not create a doctor-patient relationship. Always seek the direct advice of your doctor in connection with any questions or issues you may have regarding your own health or the health of others.